Patrick Yang - Amyris Director

AMRSDelisted Stock  USD 0.04  0  8.64%   

Director

Dr. Patrick Y. Yang is Director of Amyris Inc., effective of July 1, 2014 since 2014.
Age 69
Tenure 10 years
Phone510 450 0761
Webhttps://amyris.com
Yang served as Executive Vice President and Global Head of Technical Operations for F. HoffmannLa Roche Ltd., where he was responsible for Roche’s pharmaceutical and biotech manufacturing operations, process development, quality, regulatory, supply management and distribution functions. Before joining Roche, Dr. Yang worked for Genentech Inc., where he most recently served as Executive Vice President of Product Operations, and was responsible for manufacturing, process development, quality, regulatory affairs and distribution functions. Prior to joining Genentech Inc., Dr. Yang worked for Merck & Co., where he held several leadership roles including Vice President of Asia/Pacific Manufacturing Operations and Vice President of Supply Chain Management. He also previously worked at General Electric Co. and Life Systems, Inc

Patrick Yang Latest Insider Activity

Tracking and analyzing the buying and selling activities of Patrick Yang against Amyris stock is an integral part of due diligence when investing in Amyris. Patrick Yang insider activity provides valuable insight into whether Amyris is net buyers or sellers over its current business cycle. Note, Amyris insiders must abide by specific rules, including filing SEC forms every time they buy or sell Amyris'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Amyris Management Efficiency

The company has return on total asset (ROA) of (0.464) % which means that it has lost $0.464 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.3208) %, meaning that it created substantial loss on money invested by shareholders. Amyris' management efficiency ratios could be used to measure how well Amyris manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 981.55 M in liabilities with Debt to Equity (D/E) ratio of 1.62, which is about average as compared to similar companies. Amyris Inc has a current ratio of 0.86, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Amyris until it has trouble settling it off, either with new capital or with free cash flow. So, Amyris' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amyris Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amyris to invest in growth at high rates of return. When we think about Amyris' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Steven HutchesonAemetis
63
Christian HenryPacific Biosciences of
50
Lucy ShapiroPacific Biosciences of
77
Lydia BeebeAemetis
64
Marshall MohrPacific Biosciences of
62
David BotsteinPacific Biosciences of
75
Pam ChengCodexis
47
Ruth DreessenGevo Inc
61
Kathy OrdonezPacific Biosciences of
67
William EricsonPacific Biosciences of
59
John BlockAemetis
82
Kathleen GlaubCodexis
64
Gary MizeGevo Inc
67
Francis BartonAemetis
69
Randy LivingstonPacific Biosciences of
60
Brook ByersPacific Biosciences of
70
David SmithCodexis
58
Johannes RothGevo Inc
38
Harold SorgentiAemetis
80
Randall LivingstonPacific Biosciences of
64
John MilliganPacific Biosciences of
57
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. Amyris operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 980 people. Amyris Inc (AMRS) is traded on NASDAQ Exchange in USA and employs 1,598 people.

Management Performance

Amyris Inc Leadership Team

Elected by the shareholders, the Amyris' board of directors comprises two types of representatives: Amyris inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amyris. The board's role is to monitor Amyris' management team and ensure that shareholders' interests are well served. Amyris' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amyris' outside directors are responsible for providing unbiased perspectives on the board's policies.
Raymond Williams, Independent Director
Karen Weaver, Principal Accounting Officer, Vice President - Finance
Peter Denardo, Director of Investor Relations and Corporate Communications
Lisa Qi, Director
Patrick Yang, Director
Philippe Boisseau, Director
Caroline Hadfield, Pres Aprinnova
Margaret Georgiadis, Director
Kathleen Valiasek, CFO
Jonathan Wolter, Interim CFO
Anthony Hughes, Chief Accounting Officer
Karen Rohde, Chief Human Resources Officer
Tina Maloney, Chief Accounting Officer
Christophe Vuillez, Director
Nicole Kelsey, Chief Sec
Oreste Fieschi, President of Sweeteners and Ingredients
Raffi Asadorian, CFO
Carole Piwnica, Independent Director
Eduardo Alvarez, Chief Officer
James McCann, Director
Hermanus Kieftenbeld, CFO Officer
Christine Ofori, Chief Officer
John Melo, CEO and President and Director
Philip Eykerman, Director
Abdullah Thani, Independent Director
Christoph Goppelsroeder, Director
Charles Kraft, VP Devel
Neil Williams, Independent Director
Fernando Reinach, Independent Director
Abraham Klaeijsen, Director
Elizabeth CPA, Chief Controller
Geoffrey Duyk, Independent Director
Nicholas Khadder, Sr. VP, General Counsel and Corporate Secretary
Joel Cherry, President of RandD
Frank Kung, Director
Chris Jaenike, Interim General Counsel
Jim Iacoponi, VP Ingredients
John Doerr, Independent Director
Steven Mills, Director

Amyris Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amyris a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Amyris

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amyris position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amyris will appreciate offsetting losses from the drop in the long position's value.

Moving against Amyris Stock

  0.94XOM Exxon Mobil Corp Earnings Call This WeekPairCorr
  0.92CHKEZ Chesapeake EnergyPairCorr
  0.91CHKEL Chesapeake EnergyPairCorr
  0.86AA Alcoa Corp Financial Report 17th of July 2024 PairCorr
  0.86BAC Bank of America Financial Report 16th of July 2024 PairCorr
The ability to find closely correlated positions to Amyris could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amyris when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amyris - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amyris Inc to buy it.
The correlation of Amyris is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amyris moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amyris Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amyris can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in Amyris Stock

If you are still planning to invest in Amyris Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amyris' history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
CEOs Directory
Screen CEOs from public companies around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world